# Completeness Review: AIPharmacyOperationsManager

- **Review date:** 2026-07-18
- **Assessment basis:** Static source and configuration inspection only. Dependencies were not installed, and no build, database migration, external integration, or runtime workflow was executed.

## Classification

**Functional but incomplete**

## Verdict

This is a substantive but unfinished clinical/health application: 104 project-owned source files and 2 manifest(s) expose a coherent surface, but the source does not demonstrate a production-complete AIPharmacy Operations Manager workflow.

## Why it is not complete

- 24 files are explicitly named as gap/backlog surfaces, so page and route counts overstate implemented product capability.
- 33 project-owned files contain direct provider/chat-completion markers; generic model calls are not a substitute for typed domain tools, grounded evidence, deterministic rules, or evaluations.
- 26 files contain mock, sample, placeholder, simulated, or random-data signals, leaving important outcomes disconnected from authoritative systems.
- No explicit schema or migration evidence was found for durable, versioned domain state.
- No recognizable project-owned automated tests were found for the primary workflow.
- No checked-in CI workflow was found to continuously verify builds, tests, migrations, and security checks.
- No environment example/template was found, leaving required configuration and secret boundaries undocumented.

## Needed features

1. Implement prescription intake, patient/profile matching, pharmacist verification, DUR checks, fill/partial-fill, labeling, pickup/delivery, cancellation, and refill state transitions.
2. Integrate certified e-prescribing, PBM/claim adjudication, prescriber, wholesaler, inventory/lot/expiry, payment, and notification systems with reconciliation.
3. Add allergy, interaction, duplicate-therapy, dose/range, contraindication, controlled-substance, substitution, and cold-chain checks backed by authoritative drug data.
4. Support perpetual inventory, receiving, cycle counts, recalls, returns, waste, shortages, prior authorization, claim rejects, reversals, and audit exports.
5. Require pharmacist approval, role separation, patient consent/privacy, immutable dispensing evidence, jurisdiction-aware rules, and downtime procedures.
6. Test claim divergence, unavailable stock, partial fills, duplicate prescriptions, recalls, prescriber changes, offline recovery, and label accuracy in CI.

## Risks or launch blockers

- Incorrect or unreviewed output can cause patient harm.
- Health data requires strong privacy, access, retention, and audit controls.
- The root launcher can terminate unrelated processes occupying configured ports.
- The root launcher seeds, creates, migrates, or otherwise mutates database state during startup.
- The root launcher installs dependencies at run time, reducing reproducibility and expanding supply-chain risk.

## Evidence inspected

- `backend/package.json` — inspected project-owned structure or implementation evidence.
- `backend/server.js` — inspected project-owned structure or implementation evidence.
- `backend/routes/gapFeat_aiadvanced_js_and_airesults_js_exist_but_tsv_shows.js` — inspected project-owned structure or implementation evidence.
- `start.sh` — inspected project-owned structure or implementation evidence.
- `backend/ai.js` — inspected project-owned structure or implementation evidence.
- `backend/db.js` — inspected project-owned structure or implementation evidence.

## Recommended next action

Choose one production clinical/health journey, connect its authoritative systems, define measurable acceptance tests, and close its data, permission, failure, and operational gaps before adding screens.

## Implementation progress

1. Implemented a durable prescription lifecycle from received through patient match, DUR, pharmacist review, approval, fill/partial fill, label, ready, pickup/delivery, cancellation, and reversal with optimistic versions and append-only evidence.
2. Partially implemented certified integrations: durable provider/standard operations record idempotency, retries, rejects, failures, receipts, reconciliation, and reversal. Certified eRx/NCPDP, PBM, prescriber, wholesaler, payment, and notification connections remain closed gates.
3. Implemented deterministic DUR reason enumeration for allergy, interaction, duplicate therapy, dose range, contraindication, controlled substances, substitution, and cold chain, with terminology/profile versions in durable review records. Authoritative drug data licensing and pharmacist validation remain gates.
4. Partially implemented operations state: durable fills, lot/expiry, inventory events, recalls, returns, waste, corrections, integration rejects/reversals, and audit exports are represented. Full perpetual-inventory reconciliation, PA workflows, and downtime execution remain required.
5. Implemented pharmacist authority for consequential states, independent cleared DUR approval based on the latest database record, tenant scoping, immutable dispensing/reversal evidence, mandatory configuration, and generated-route quarantine. Jurisdictional policy and downtime governance remain gates.
6. Implemented 6 focused tests covering divergence/safety/approval/evidence boundaries, dependency-free CI, explicit transactional migration, a non-destructive launcher, and operations documentation. Stock/label/offline tests requiring authoritative fixtures remain required before deployment.
